GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Other Current Assets

Microba Life Sciences (ASX:MAP) Other Current Assets : A$-0.00 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Other Current Assets?

Microba Life Sciences's other current assets for the quarter that ended in Dec. 2023 was A$-0.00 Mil.

Microba Life Sciences's quarterly other current assets increased from Dec. 2022 (A$1.02 Mil) to Jun. 2023 (A$1.60 Mil) but then declined from Jun. 2023 (A$1.60 Mil) to Dec. 2023 (A$-0.00Mil).

Microba Life Sciences's annual other current assets increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$1.45 Mil) increased from Jun. 2022 (A$1.45 Mil) to Jun. 2023 (A$1.60 Mil).


Microba Life Sciences Other Current Assets Historical Data

The historical data trend for Microba Life Sciences's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Other Current Assets Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Other Current Assets
1.45 1.60

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Assets 0.58 1.45 1.02 1.60 -

Microba Life Sciences Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Microba Life Sciences Other Current Assets Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines